Lobectomy leads to optimal survival in early-stage small cell lung cancer: A retrospective analysis

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 3, 2011, Pages 538-546

  Varlotto, John M ^a   Recht, Abram ^b   Flickinger, John C ^c   Medford Davis, Laura N ^d   Dyer, Anne Marie ^e   Decamp, Malcolm M ^f  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG LOBECTOMY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR VOLUME;

EID: 80051784354     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.11.062     Document Type: Article

References (29)

1. C.L. Hann, and C.M. Rudin Management of small-cell lung cancer: incremental changes but hope for the future Oncology 22 2008 1486 1492
2. W. Fox, and J.G. Scadding Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of the bronchus. Ten-year follow-up Lancet 2 1973 63 65
3. M.B. Beasley, E. Brambilla, and W.D. Travis The 2004 World Health Organization classification of lung tumors Semin Roentgenol 40 2005 90 97 (Pubitemid 40417889)
4. M. Fukuoka, K. Furuse, and N. Saijo Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternations of these regimens in small-cell lung cancer J Natl Cancer Inst 83 1991 855 861
5. B.E. Johnson, J. Crawford, and R.J. Downey Small cell lung cancer clinical practice guidelines in oncology J Natl Compr Canc Netw 4 2006 602 622 (Pubitemid 44265467)
6. A. Takeda, N. Sanuki, and E. Kunieda Stereotactic body radiotherapy for primary lung cancer at a dose of 50Gy total in five fractions to periphery of the planning target volume calculated using a superposition algorithm Int J Radiat Oncol Biol Phys 73 2009 442 448
7. T. Ioue, S. Shimizu, and R. Onimaru Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687 Epub 2009 Feb 21
8. C.J. Haasbeek, F.J. Lagerwaard, and K. de Jaeger Stage I lung cancer arising postpneumonectomy Cancer 115 2009 587 594
9. P. Baumann, J. Nyman, and M. Hoyer Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer: a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
10. Surveillance, Epidemiology, and End Results (SEER) program public-use data (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Statistics Branch. Available at: http://seer.cancer.gov/publicdata/. Accessed February 3, 2009.
11. Surveillance, Epidemiology and End Results (SEER) Program Web Site. Data quality. Available at: http://seer.cancer.gov/about/quality.html. Accessed February 3, 2009.
12. Greene FL, Compton CC, Fritz AG, Shah JP,Winchester DP, eds. Thorax: lung. In: American Joint Committee on Cancer Staging atlas. Part III. Chicago: Springer; 2006:167-76.
13. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
14. E.S. Kaplan, and P. Meier Non-parametric estimation from incomplete observation Am Stat Assoc 53 1958 475 480
15. T. Lad, S. Piantadosi, and P. Thomas A Prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung cancer to combination chemotherapy Chest 106 1994 320 323
16. E. Vallires, F.A. Shepherd, J. Crowley International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer J Thorac Oncol 4 2009 1049 1059
17. Lung Cancer Study Group Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer Ann Thorac Surg 60 1995 615 623
18. A.T. Turrissi, K. Kim, and R. Blum Twice-daily compared with once-daily thoracic radiotherapy in limited-stage small-cell lung cancer treated concurrently with cisplatin and etoposide N Engl J Med 340 1999 265 271 (Pubitemid 29063268)
19. F.A. Shepard, J. Crowley, and P. Van Houtte The International Association for the Study of Lung Cancer Staging Project, lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer J Thorac Oncol 2 2007 1067 1076
20. B.E. Lally, A.M. Geiger, and J.J. Urbanic Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database Lung Cancer 64 2009 226 231
21. D. Schreiber, J. Rineer, and J. Weedon Survival outcomes with the use of surgery in limited-stage small cell lung cancer Cancer 116 2010 1350 1357
22. M.H. Gail, R.T. Eagen, and R. Feld Prognostic factors in patients with resected stage I non-small cell lung cancer, a report from the Lung Cancer Study Group Cancer 54 1984 1802 1813 (Pubitemid 14020608)
23. J.M. Varlotto, A. Recht, and J.C. Flickinger Factors associated with local and distal recurrence and survival in patients with resected non-small cell lung cancer Cancer 115 2009 1059 1069
24. C.I. Henschke, D.F. Yankelevitz, and D.M. Libby Survival of patients with stage I lung cancer detected on CT Screening N Engl J Med 355 2006 1763 1771 (Pubitemid 44631359)
25. M.V. Graham, J.A. Purdy, and B. Emami Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 45 1999 323 329 (Pubitemid 29408545)
26. R.M. Pieterman, J. van Putten, and J.J. Meuzelaar Preoperative staging of non-small cell lung cancer with positron-emission tomography N Engl J Med 343 2000 254 261 (Pubitemid 30490393)
27. N. Hanna, P.A. Bunn, and C. Langer Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer J Clin Oncol 24 2006 2038 2043 (Pubitemid 46622112)
28. R.B. Natale, P.N. Lara, and K. Chansky A randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin(EP) in patients(pts) with previously untreated extensive stage small cell carcinoma(E-SCLC). Abstract 7512 J Clin Oncol 26 15S 2007 400S
29. J.P. Pignon, R. Arriagada, and D.C. Ihde A meta-analysis of thoracic radiotherapy for small-cell lung cancer N Engl J Med 327 1992 1618 1624